Ticker brief
IMTX
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
8
authors 14d
7
crowd 14d
-0.9σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-18 → 2026-08-28 · now +0.30 (−1 bearish … +1 bullish)
Who spoke7
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @sunxliao | B | -2.09 | 2 | +0.25 |
| @EmmanuelInvest | C | -1.11 | 1 | +0.55 |
| @BioStocks | C | -3.02 | 1 | -0.35 |
| @PersimmonTI | A | -0.57 | 1 | +0.20 |
| @OpenOutcrier | C | · | 1 | -0.30 |
| @BiopharmIQ | B | · | 1 | -0.20 |
| @Maximus_Holla | C | +0.80 | 1 | +0.30 |
Recent signals8of 8 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @sunxliao | +0.30 | Lists positive intraday performance for five stocks | · | tweet ↗ |
| 2026-08-27 | @sunxliao | +0.20 | Lists stocks displaying the author's blue-diamond technical indicator. | · | tweet ↗ |
| 2026-08-27 | @Maximus_Holla | +0.30 | Reports insider buying in IMTX. | · | tweet ↗ |
| 2026-08-25 | @BiopharmIQ | -0.20 | Biotech news roundup lists movers and catalysts; first six explicit tickers retained. | · | tweet ↗ |
| 2026-08-25 | @OpenOutcrier | -0.30 | Immatics announced a $150M underwritten equity offering. | · | tweet ↗ |
| 2026-08-25 | @PersimmonTI | +0.20 | Author positively characterizes price discovery, but the attached chart is required. | · | tweet ↗ |
| 2026-08-25 | @BioStocks | -0.35 | IMTX priced a $150M equity offering at $8.69 per share. | · | tweet ↗ |
| 2026-08-18 | @EmmanuelInvest | +0.55 | Frames Immatics as a high-risk PRAME oncology story with strong data, cash runway and 2027 catalysts | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.